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Abstract Objective General practitioners and pharma-
cists do not properly educate their patients about the
disadvantages of benzodiazepines. In order to increase and
improve education, this study will investigate which psy-
chological factors (i.e., beliefs, outcome expectation, social
norm and self-efﬁcacy) predict the intention to educate.
Methods A cross-sectional survey study was conducted in
which 339 general practitioners and 149 pharmacists in
the Netherlands completed a questionnaire. Results The
Results show that the above-mentioned factors play an
important role in forming intentions to educate. However,
differences exist between general practitioners and phar-
macists. Conclusion General practitioners and pharmacists
intend to educate in cases where they think that benzodi-
azepines have well-deﬁned disadvantages, when the
education they undertake leads to success, when they feel
pressure to educate from their surroundings and when they
are capable of educating. Implications for practice These
ﬁndings contribute to a better understanding of patient
education and are of great value in developing new inter-
ventions to improve education.
Keywords Benzodiazepine use  General practitioner 
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Psychological factors
Impact of ﬁndings on practice
• Our ﬁndings will result in a better understanding of
patient education about the disadvantages of benzodi-
azepine use.
• Our results can be used to develop new interventions to
improve education about benzodiazepine use.
Introduction
Benzodiazepines are commonly prescribed drugs aimed
at the short-term relief of severe, disabling anxiety or
insomnia. The use of benzodiazepines has only been pro-
ven effective when used short term [1–5]. Long-term use is
not only non-effective, it can even be problematic because
it is related to several negative health effects such as
addiction, falls, hip fractures, phases of depression and
impaired cognition [6–17]. Because of this, guidelines for
general practitioners have been established, for example,
by the Dutch College of General Practitioners (NHG)
regarding how and when to prescribe benzodiazepines to
patients. Benzodiazepines for sleep disorders, for instance,
are recommended for at most 10–14 days [18].
Despite these recommendations, 10–15% of the popu-
lation uses benzodiazepines on a regular basis, and 3% uses
them chronically [19]. The elderly are the most common
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DOI 10.1007/s11096-007-9183-2users: 42% of all users are 65 or older. They take 2.9 times
more benzodiazepines than their younger counterparts.
Those who are 75 years or older take even four times as
much [20, 21]. The number of prescriptions for benzodi-
azepines in 2003 was almost eleven million and continues
to grow by 1% each year [22, 23]. In addition, other
European and non-European countries like the United
States have to contend with widespread use of benzodi-
azepines [24]. Given the long-term adverse effects of
benzodiazepine use and the high costs associated with the
high number of prescriptions, it is essential that both pre-
scriptions for benzodiazepines be reduced and that patients
be well informed about the (in)effectiveness and (adverse)
effects of long-term benzodiazepine use.
The latter is often lacking: it is known that the education
offered by health practitioners to patients is often inade-
quate and that alternatives like counselling or referral to
other services are not offered in most instances [25, 26].
Two groups can be distinguished in patient education:
general practitioners and pharmacists. Although they have
different roles, they are both responsible for informing and
educating patients about the use of drugs. In the Nether-
lands pharmacists and general practitioners need to comply
with the same law of medicine [27].
Today, it is known that education about the disad-
vantages of benzodiazepine use is often non-existent: 80%
of prescription reﬁlls are handed out by the assistant
instead of general practitioners seeing the patient them-
selves [22]. As a result, most patients are not educated at
all. This is surprising because education would result in
more satisﬁed patients, along with a better understanding
of the pros and cons of medication, and more compliance
to treatment [28–30]. It is also known that when they do
educate, general practitioners and pharmacists can play a
vital role in changing patients’ attitudes towards medicine
use. For instance, it has been shown that pharmacists
can play an important role in changing the drug attitudes
of depressive patients [31]. Thus, we can conclude that
educating by both general practitioners and pharma-
cists the benzodiazepine user can have positive results
in terms of the goal of reducing the amount of
benzodiazepines.
But why is it that general practitioners and pharmacists
do not educate their patients well? In case of general
practitioners on the one hand, it is known that they lack the
time [30, 32–34]. In addition to this, the workload of the
general practitioner is even higher when health problems
are psychological or social in nature, as these problems
take up more time than physical problems [35, 36]. This is
the case with benzodiazepines: the reasons why patients
start taking benzodiazepines mostly stem from stress,
trauma or acute anxiety [30]. High prescription levels of
benzodiazepines are also related to the uncertainty of
general practitioners about suggesting alternatives [30, 37].
And they are unwilling to raise the issue of benzodiazepine
withdrawal because they view an intervention as pointless
[30]. Although pharmacists, on the other hand, are eager to
undertake an extended role in health education, it is still
uncommon for them to educate their patients, like drawing
attention to leaﬂets displayed, or to actively provide
patients with verbal education. Besides this, they are not
always certain in educating patients about the effects and
possible disadvantages of drugs in general [38, 39]. In
order to stimulate patient education by both general prac-
titioners and pharmacists about benzodiazepine use it is
important to develop an intervention that is based on the
psychological causes behind educating behaviour. It is
important, therefore, for an intervention to be developed
that targets these psychological causes related to educating
patients.
Behaviour change—from not educating patients to
educating them properly—starts with the formulation of
the intention to educate. Intentions to perform speciﬁc
behaviours have been shown to be the most powerful
psychological predictors of actual behaviour [40, 41]. To
distil the psychological determinants of the intention to
educate, we will make use of psychological determinants
derived from different models (i.e., Theory of Planned
Behaviour [42], Protection Motivation Theory [43], and
Social Cognitive Theory [44]). These models have been
shown to have good predictive value in a diversity of
behaviours such as individual health behaviour like
tobacco use [45] and drinking behaviour [46, 47], but also
in predicting behaviour of individuals at other societal
levels such as teachers providing sex education [48]o r
predicting the intention to vote for law enforcement by
politicians [49]. The above models all acknowledge that
intention is the most proximal determinant of behaviour
and that intention is in turn predicted by beliefs, outcome
expectations (positive and negative), social norm and self-
efﬁcacy. Therefore, the aim of this study is to assess the
psychological factors that predict the intention of general
practitioners and pharmacists to educate their patients
about benzodiazepine use.
Method
Participants and design
A cross-sectional survey study was conducted in order to
assess the psychological determinants of intention to edu-
cate by general practitioners and pharmacists. Addresses of
general practitioners and pharmacists were selected from
an electronic version of the Dutch telephone directory. In
total 999 general practitioners and 605 pharmacists were
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123randomly chosen. Surveys were then sent to these general
practitioners and pharmacists.
Questionnaire
The questionnaire assessed demographic data such as age,
the amount of time the general practitioners and pharma-
cists were active in their profession, the number of patients
they had in their ﬁles, and the number of prescriptions were
handed over.
Intention, beliefs, outcome expectations, social norm
and self-efﬁcacy were measured on a ﬁve-point scale:
‘deﬁnitely not’ [1], ‘probably not’ [2], ‘neutral’ [3],
‘probably yes’ [4], and ‘deﬁnitely yes’ [5]. Intention was
measured with two questions. The two questions were: ‘In
the next 12 months are you planning to educate patients
who start taking benzodiazepines or renew their use, about
the disadvantages of benzodiazepines?’ and ‘In the next
12 months are you planning to educate patients who are
already taking benzodiazepines?’.
Beliefs, outcome expectations, social norm and self-
efﬁcacy were measured as follows. The beliefs regarding
benzodiazepine use were response-efﬁcacy and disadvan-
tages. Response-efﬁcacy was measured with two items, for
example, ‘Benzodiazepines are not effective’. Disadvan-
tages were measured by three items. One example was
‘Patients who use benzodiazepines for more than 3 months
become addicted to them’. The psychological factors
towards patient education were outcome expectations,
social norm and self-efﬁcacy. Positive outcome expecta-
tions were measured by three items. One item was ‘If I
educate my patients about the disadvantages of benzodi-
azepines, they will beneﬁt from that’. Negative outcome
expectations were also measured by means of three items.
One example was ‘If I educate my patients about the dis-
advantages of benzodiazepines, this will present a risk for
the doctor–patient relationship’. Three items refer to social
norm. One example is ‘Do you think that KNMP (Royal
Dutch Pharmaceutical Society, an association for and by
pharmacists in the Netherlands) or NHG (Dutch College of
General Practitioners) expects you to educate about ben-
zodiazepines’. Lastly, self-efﬁcacy was measured by one
item ‘It is difﬁcult to educate patients about the disad-
vantages of benzodiazepines’ (recoded).
Results
A total of 339 general practitioners (34%) and 149 (25%)
pharmacists completed and returned the questionnaires.
The mean age of the general practitioner was 48.5 years
and that of the pharmacist was 39 years. Their average
practice experience was 17.3 and 12.5 years respectively.
An average of 2,545 patients were enrolled at the general
practice. At the pharmacy, there were 10,037 patients with
80,653 prescriptions dispensed per year.
Reliability analyses showed that Cronbach’s Alpha’s
were low to high: intention (2 items, a = 0.66), response-
efﬁcacy (2 items, a = 0.76), disadvantages (3 items, a =
0.62), positive outcome expectations (3 items, a = 0.75),
negative outcome expectations (3 items, a = 0.63), and
social norm (3 items, a = 0.58).
Table 1 gives a summary of the differences in mean
scores and standard deviations on the psychological factors
between general practitioners and pharmacists. T-tests were
conducted to examine differences between the psycholog-
ical factors of general practitioners and pharmacists.
Signiﬁcant differences were found for intention (t(478) =
12.1; P\0.001), negative outcome expectations (t(476) =
2.8; P\0.05), social norm (t(476) = 4.0; P\0.001) and
self-efﬁcacy (t(471) = 4.5; P\0.001). These differences
suggest that general practitioners have a more positive
intention (95.5% of the general practitioners were intend-
ing to educate in contrast to 72.1% of the pharmacists), that
they expect more negative outcomes when they do educate,
that they experience a more positive social norm and that
they feel more capable of educating their patients than do
Table 1 Differences in mean scores (M) and standard deviations (SD) on the psychological factors between general practitioners and
pharmacists
Items General practitioner Pharmacist tP
Range M (SD) M (SD) df
Intention 2 1–5 4.0 (0.8) 3.1 (0.8) 478 12.1 \.001
Response-efﬁcacy 2 1–5 4.1 (1.0) 4.0 (1.1) 477 .7 .48
Disadvantages 3 1–5 4.3 (0.7) 4.3 (0.7) 478 .4 .69
Positive outcome expectation 3 1–5 2.5 (0.8) 2.4 (0.9) 477 -1.1 .28
Negative outcome expectation 3 1–5 2.5 (1.0) 2.2 (1.0) 476 2.8 \.05
Social norm 3 1–5 3.8 (0.8) 3.5 (0.8) 476 4.0 \.001
Self-efﬁcacy 1 1–5 1.9 (1.1) 2.4 (1.0) 471 4.5 \.001
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123pharmacists. They did not differ signiﬁcantly on both sets
of beliefs on the effects of benzodiazepines (response
efﬁcacy and disadvantages), nor on positive outcomes they
expect from educating patients.
Separate regression analyses were conducted for general
practitioners and pharmacists whereby intention was
regressed on response efﬁcacy, disadvantages, outcome
expectations (positive and negative), social norm and self-
efﬁcacy (Table 2). For the general practitioners, the
regression of intention to educate explained a variance of
R
2 = 0.15, with disadvantages, negative outcome expec-
tations, social norm and self-efﬁcacy being signiﬁcant
determinants. When we looked at the pharmacists, the
regression yielded an R
2 of 0.22, with only positive out-
come expectations and social norm being signiﬁcant
determinants. Thus, general practitioners’ intention to
educate was higher when they saw more disadvantages
from benzodiazepine use, when they expected less negative
outcomes from their education, when they perceived more
social pressure to educate, and when they thought they
were more capable of educating. Pharmacists’ intention to
educate was higher, on the other hand, when they saw more
positive outcomes for their education efforts, and when
they perceived more social pressure to educate.
Discussion
In the present study predictors of intended benzodiazepine
education were examined among general practitioners and
pharmacists. The main ﬁndings were that beliefs, outcome
expectations (positive and negative), social norm and self-
efﬁcacy played a role in forming intentions to educate.
However, differences existed among practitioners. In the
case of general practitioners, intention was predicted by
beliefs, negative outcome expectations, social norm and
self-efﬁcacy, whereas intention of pharmacists to educate
was only predicted by positive outcome expectations and
social norm. These ﬁndings suggest that when persuading/
reinforcing general practitioners and pharmacists to edu-
cate, different information needs to be provided to each
group in order to ensure patient education.
A possible explanation for the differences found between
general practitioners and pharmacists is the fact that general
practitioners are actually educating on a daily basis, while
this is not the case with pharmacists. In the present study,
91% of the general practitioners indicated that they educated
their patients when these started taking benzodiazepines,
contrary to 47% of the pharmacists. In the Netherlands
pharmacists, unlike general practitioners, are since July 2007
under an obligation to educate [27]. As such, the differences
in psychological determinants found may be related to the
(lack of) experience that general practitioners and pharma-
cists have regarding patient education. In other words, due to
the experience of general practitioners, they are more likely
to report the barriers and negative consequences of patient
education, while pharmacists, on the other hand, might base
their expectations on hypothetical situations, not having
experienced the drawbacks of educating patients. Another
possibility is that general practitioners have a more personal
relationship with their patients than pharmacists have. Thus,
general practitioners know the difﬁculties patients experi-
ence in quitting benzodiazepines. Although these explana-
tions are speculative, it seems probable that these differences
found would imply practical differences for general practi-
tioners and pharmacists.
Practice implications
Because it is now known that beliefs, outcome expectations,
social norm and self-efﬁcacy are responsible for the inten-
tion to educate, this knowledge can be used in order to get
thegeneralpractitionerandpharmacist tobemore motivated
in educating their patients. These determinants must now be
translated into practical strategies. First of all, in order to get
the general practitioners and pharmacists to realise the
importance of educating, it is necessary to increase their
awareness by extending their knowledge about the desir-
ability of patient education on benzodiazepine use. Beliefs
andoutcomeexpectancies canchange dueto new persuasive
arguments,andasa resultoftheenhancement ofthesalience
of information already possessed and along with linking
beliefs with personal values [50]. This can be achieved, for
example, by information leaﬂets, pamphlets, seminars, lec-
tures and so on. From this study, it is particularly important
to keep the differences between these two kinds of practi-
tioners in mind. For the general practitioners it is especially
Table 2 Regression of intention on the psychological factors for
general practitioners and pharmacists
Intention to educate
General practitioner Pharmacist
ß PR
2 (F)ß PR
2 (F)
Response-
efﬁcacy
.02 .75 .15 (9.8) .06 .53 .22 (6.1)
Disadvantages .27 .00 .12 .19
Positive
outcome
expectation
-.01 .87 .19 .03
Negative
outcome
expectation
-.11 .03 -.07 .36
Social norm .12 .03 .23 .01
Self-efﬁcacy -.14 .01 .12 .17
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123important to reduce negative outcome expectations by tell-
ing them that education will not harm the relationship with
others (such as the relationship with the patient or pharma-
cist) and that education will not require too much time and
effort on the long-term. For the pharmacist, on the other
hand, it is particularly important to promote the positive
outcomes of educating by for example underlining the fact
that education will result in less benzodiazepine use, that
patients will have a lower risk of falling and that the patient
will beneﬁt as a result.
Secondly, methods of inﬂuencing social norms are
anchored in providing information on group norms [51].
General practitioners and pharmacists are also likely to
increase or sustain their education efforts towards benzodi-
azepine users when important social inﬂuences are activated,
such as professional federations like the Royal Dutch
Pharmaceutical Society and the Dutch Society of General
Practice. These federationscan putpolicies into place, which
ensure that (recurrent) patient education and monitoring
becomes part of daily practice. And ﬁnally, methods for self-
efﬁcacy enhancement include skills training, mastery expe-
rience and modelling. All this must be combined with
feedback and reinforcement. It is widely known that in order
to increase conﬁdence (i.e., self-efﬁcacy) people need
encouragement and successful experiences [52].
The present ﬁndings have addressed determinants that
need to be targeted in order to facilitate an intervention that
ensures patient education of general practitioners and
pharmacists. Additional factors such as, for example,
environmental factors, need to be formulated in further
studies. These will then contribute to a deeper under-
standing of how benzodiazepine education interventions
can be best implemented. Thus, more research is necessary.
Instead of looking at possible solutions for improving the
education of general practitioners and pharmacists, it is also
important to look at other ways to have patients educated.
As has been described elsewhere [35, 53–55], it also turns
out in this study, that general practitioners and pharmacists
suffer from time constraints: more than 38% of the
respondents think that educating patients takes too much
time. For that reason it is important that work be taken off
the practitioners’ hands. A tool which educates patients
automatically would therefore be handy. It is known that
writing a standard letter to patients already reduces ben-
zodiazepine intake [56–59]. However, personalized letters
produced by a computer program, meaning without even
seeing the patient, appear to be even more effective [60].
Limitations
Caution is warranted in interpreting the results of this
study. First, low to high Cronbach’s Alphas were found
and low variances were found in the scales representing
intention to educate and psychological factors predicting
intention to educate. This may be due to the fact that the
number of items for each factor was limited. This was
done intentionally to increase response rate as it is known
that health practitioners are not likely to participate [61].
The questionnaire was therefore minimized to attract
them. The sample used in this study might also cause a
stir. Around 70% of those who received questionnaires did
not respond. However, according to Swanborn, a response
rate of 30% is not bad for this type of research in the
Netherlands [62]. Also, it is known that response rates
among health practitioners are low due to time constraints,
among other things [61]. Also comparing our participants
with the Dutch population it is known that a general
practitioner in the Netherlands has on average 2,053
patients per practice [63]. According to the Foundation for
Pharmaceutical Statistics [22] Dutch pharmacies on aver-
age attend to 8,700 patients per pharmacy and process
73,800 prescriptions a year. It thus looks like we were
dealing with a representative sample. Most importantly,
studies are still important in order to identify common
problems in health care systems [64]. This also applies to
the present study: it tries to ﬁnd an answer to why general
practitioners and pharmacists do not educate as they
should.
Conclusion
In the present study predictors of intended benzo-
diazepine education were examined among general
practitioners and pharmacists. The main ﬁndings were
that beliefs, outcome expectations (positive and nega-
tive), social norm and self-efﬁcacy played a role in
forming intentions to educate. However, differences
existed among practitioners. This study is the ﬁrst Dutch
study that has mapped the psychological factors of
intention to educate patients about benzodiazepines. A
start has thus been made in understanding the motives of
general practitioners and pharmacists when it comes to
educating.
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